MedPath

Newlife Fertility Centre

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

The Role of Granulocyte Colony Stimulating Factor in Embryo Transfer Outcomes

Phase 4
Recruiting
Conditions
Infertility Unexplained
Infertility
Infertility of Uterine Origin
Infertility; Female, Nonimplantation
Infertility,Female
Interventions
Drug: Granulocyte Colony-Stimulating Factor (Filgrastim)
Other: Standard Embryo Transfer Media
First Posted Date
2023-12-18
Last Posted Date
2024-03-21
Lead Sponsor
Newlife Fertility Centre
Target Recruit Count
300
Registration Number
NCT06174298
Locations
🇨🇦

Newlife Fertility Centre, Mississauga, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath